Key facts
- Notable investors include Portland Seed Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kapha Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Kapha Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kapha Bio
Operator of a biomaterial company intended to engineer seamless defense against recurrent infections. The company offers patented biomaterials to bolster defenses against pathogenic bacteria throughout the body, enabling customers to be safeguarded against recurrent infections and liberated from disruptive cycles of infection.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2024
- Employees
- 4
- Website
- kaphabio.com/
- Ownership
- Privately Held (backing)
Kapha Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kapha Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kapha Bio in its N-PORT filings yet. We sweep new filings monthly.